-
Research partnership aims to build strong pharma and academic collaborations in sharing data and clinical samples to develop biomarker-based diagnostics for Alzheimer’s Disease
Dec 11, 2023
-
Dec 11, 2023
-
Dec 10, 2023
-
Dec 6, 2023
-
Dec 6, 2023
-
Dec 5, 2023
-
Modernizing the 150-year-old microscope-based practice with digital innovation
Dec 6, 2023
-
VERICHEM offers calibration verification materials for the testing of both urine and serum Magnesium assays.
Dec 3, 2023
-
Dear Nicole,
Biotium, a leading provider of innovative solutions for life science research, has announced the launch of Biotium Choice primary antibody conjugates. With careful curation and extensive in-house validation, Biotium Choice monoclonal primary antibodies are designed to deliver exceptional performance for flow cytometry.
The release of the Biotium Choice primary antibodies adds to Biotium’s growing catalog of robust and validated probes for life science research.
Dec 3, 2023
-
PathAI, a leading digital and computational pathology company which provides precision pathology solutions has announced the availability of ArtifactDetect on AISight™, PathAI’s digital pathology image management system. This product automates the detection of artifacts on digital pathology whole slide images and quantifies the extent of artifact on any WSI.
Nov 29, 2023
-
WCG's IRB+ service has been pressure tested on 90+ studies, ensuring that it maintains the integrity and quality of board reviews while accelerating operational processing, allowing for faster site activation and study start-up.
Nov 29, 2023
-
Nov 29, 2023
-
Nov 6, 2023
-
Nov 14, 2023
-
Eremid® Genomic Services, LLC (“Eremid”) announces its College of American Pathologists (CAP) accreditation, complementing its November 2022 CLIA certification. This landmark demonstrates Eremid’s commitment to meeting and exceeding regulatory standards, proving its ability to provide quality and precision in clinical genomics. This noteworthy development cements Eremid as a trusted partner for end-to-end clinical genomics support capable of delivering high quality test results.
Nov 28, 2023
-
Exothera has announced its Nucleic Acids Chief Technology Officer, Patrick Thiaville has been nominated as a member of the Alliance for mRNA Medicines (AMM) board.
Nov 27, 2023
-
Nov 15, 2023
-
Nov 12, 2023
-
Nov 20, 2023
-
Nov 9, 2023